The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model.
The Growing Case for Use of SGLT2i in Heart Failure: Additional Benefits of Empagliflozin in a HFpEF Rodent Model. — المؤلف: Ha, Chae-Myeong — JACC. Basic to translational science Feb 2019
- المؤلف
- Ha, Chae-Myeong
- النشر
- JACC. Basic to translational science Feb 2019
- الوصف
- 38-40 p.